Table 3.
Polymorphism (reference genotype) | Comparison genotype | Large LDL, nmol/L
|
Small LDL, nmol/L
|
LDL size, nm
|
|||
---|---|---|---|---|---|---|---|
Mean (SE) | P b | Mean (SE) | P | Mean (SE) | P | ||
ABCA1 | |||||||
1051G/A (GG) | GA | −19.5 (12.9) | 0.13 | 28.0 (29.5) | 0.34 | −0.1 (0.1) | 0.12 |
| |||||||
AA | −23.6 (17.9) | 0.19 | −0.8 (40.8) | 0.99 | 0.0 (0.1) | 0.97 | |
| |||||||
CETP | |||||||
| |||||||
TaqIB (B1B1) | B1B2 | 42.5 (12.6) | 0.001 | −80.8 (28.6) | 0.005 | 0.2 (0.1) | 0.001 |
| |||||||
B2B2 | 81.0 (17.7) | 5.2 × 10−6 | −173.0 (40.3) | 1.9 × 10−5 | 0.3 (0.1) | 2.3 × 10−7 | |
| |||||||
−2505C/A (CC) | CA | 55.1 (12.2) | 6.7 × 10−6 | −114.0 (27.8) | 4.4 × 10−5 | 0.2 (0.1) | 2.8 × 10−6 |
| |||||||
AA | 87.4 (19.4) | 7.3 × 10−6 | −137.4 (44.2) | 0.002 | 0.3 (0.1) | 1.7 × 10−5 | |
| |||||||
−629C/A (CC) | CA | 25.7 (14.3) | 0.072 | −47.2 (32.5) | 0.15 | 0.1 (0.1) | 0.058 |
| |||||||
AA | 61.0 (16.4) | 2.1 × 10−4 | −128.6 (37.2) | 0.001 | 0.3 (0.1) | 7.5 × 10−6 | |
| |||||||
A373P (AA) | AP | −34.1 (19.4) | 0.08 | 135.6 (44.0) | 0.002 | −0.2 (0.1) | 0.01 |
| |||||||
PP | −300.5 (128.5) | 0.02 | 786.7 (291.1) | 0.007 | −1.2 (0.5) | 0.01 | |
| |||||||
R451Q (RR) | RQ | −16.4 (22.0) | 0.46 | 118.3 (49.9) | 0.02 | −0.2 (0.1) | 0.06 |
| |||||||
−297.7 (128.7) | 0.02 | 781.5 (291.6) | 0.007 | −1.2 (0.5) | 0.01 |
Values are adjusted for age, sex, race/ethnicity, BMI, waist circumference, diabetes, serum insulin level, smoking, and use of lipid-lowering medications.
P values are based on t-test comparing mean of comparison genotype to the indicated reference genotype for each polymorphism using a codominant model.